Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore practical guidance on the first crypto to buy as a beginner, including risk considerations and a simple decision framework.
26,337 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Inflation can squeeze many businesses, but some companies thrive by design. This article makes the case for Visa as t...
A wave of fresh research notes on Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesfo...
Hycroft Mining stock dropped 18% this week as gold and silver prices slid and investors weighed development risk. Thi...
A quantum computing stock has tumbled roughly 40% from its peak. This article weighs the risks and potential rewards,...
When top executives trim their holdings, investors pay attention. This article breaks down what a well timed trim mea...
Thinking about sell micron stock? final. This guide breaks down the drivers behind MU, risk factors, and a clear verd...
Income investors are eyeing a familiar Dividend King delivering a near-3% yield. This article breaks down what that s...
Moderna stock has surged on vaccine optimism and pipeline potential. This guide breaks down what’s behind the move, w...
Insider activity is part of every bank’s life. This guide explains how to read Form 4 disclosures and what they may m...
When a tech chief sells shares, investors take notice. This deep-dive explains what InterDigital's CTO's sale could m...
A sudden rise in sweetgreen stock often stirs chatter among traders and fans alike. This article explains the common ...